Reevaluating goals of insulin therapy: Perspectives from large clinical trials

Matthew C. Riddle, Kevin C J Yuen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recent large clinical trials have shown that intensive glycemic control can reduce microvascular complications, but appropriate and safe glycemic goals to improve macrovascular outcomes in patients with type 2 diabetes remain poorly defined. This article surveys recent epidemiologic studies and interventional trials, examines the current understanding of the natural history of type 2 diabetes, and proposes new goals and tactics for optimizing insulin therapy.

Original languageEnglish (US)
Pages (from-to)41-56
Number of pages16
JournalEndocrinology and Metabolism Clinics of North America
Volume41
Issue number1
DOIs
StatePublished - Mar 2012

Fingerprint

Type 2 Diabetes Mellitus
Clinical Trials
Insulin
Epidemiologic Studies
Therapeutics
Surveys and Questionnaires

Keywords

  • Cardiovascular risk
  • Diabetes
  • Glycemic control
  • Goals
  • Insulin
  • Macrovascular
  • Microvascular
  • Tactics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Reevaluating goals of insulin therapy : Perspectives from large clinical trials. / Riddle, Matthew C.; Yuen, Kevin C J.

In: Endocrinology and Metabolism Clinics of North America, Vol. 41, No. 1, 03.2012, p. 41-56.

Research output: Contribution to journalArticle

@article{4cc290c0cd29416db98e1af6ae110ef2,
title = "Reevaluating goals of insulin therapy: Perspectives from large clinical trials",
abstract = "Recent large clinical trials have shown that intensive glycemic control can reduce microvascular complications, but appropriate and safe glycemic goals to improve macrovascular outcomes in patients with type 2 diabetes remain poorly defined. This article surveys recent epidemiologic studies and interventional trials, examines the current understanding of the natural history of type 2 diabetes, and proposes new goals and tactics for optimizing insulin therapy.",
keywords = "Cardiovascular risk, Diabetes, Glycemic control, Goals, Insulin, Macrovascular, Microvascular, Tactics",
author = "Riddle, {Matthew C.} and Yuen, {Kevin C J}",
year = "2012",
month = "3",
doi = "10.1016/j.ecl.2012.03.003",
language = "English (US)",
volume = "41",
pages = "41--56",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Reevaluating goals of insulin therapy

T2 - Perspectives from large clinical trials

AU - Riddle, Matthew C.

AU - Yuen, Kevin C J

PY - 2012/3

Y1 - 2012/3

N2 - Recent large clinical trials have shown that intensive glycemic control can reduce microvascular complications, but appropriate and safe glycemic goals to improve macrovascular outcomes in patients with type 2 diabetes remain poorly defined. This article surveys recent epidemiologic studies and interventional trials, examines the current understanding of the natural history of type 2 diabetes, and proposes new goals and tactics for optimizing insulin therapy.

AB - Recent large clinical trials have shown that intensive glycemic control can reduce microvascular complications, but appropriate and safe glycemic goals to improve macrovascular outcomes in patients with type 2 diabetes remain poorly defined. This article surveys recent epidemiologic studies and interventional trials, examines the current understanding of the natural history of type 2 diabetes, and proposes new goals and tactics for optimizing insulin therapy.

KW - Cardiovascular risk

KW - Diabetes

KW - Glycemic control

KW - Goals

KW - Insulin

KW - Macrovascular

KW - Microvascular

KW - Tactics

UR - http://www.scopus.com/inward/record.url?scp=84860648425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860648425&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2012.03.003

DO - 10.1016/j.ecl.2012.03.003

M3 - Article

C2 - 22575406

AN - SCOPUS:84860648425

VL - 41

SP - 41

EP - 56

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 1

ER -